RARA and acute promyelocytic leukemia: In keeping with these roles for RARα, the RAR fusion proteins that arrest myeloid differentiation of APL cells function as dominant-negative inhibitors of wild-type RARα (reviewed in Tsai and Collins 1993; Yan et al. 2010).